He is also the Director of the WHO Collaborating Center for Research and Training in Stroke Prevention, Epidemiology and Surveillance and the author or co-author of over 130 articles on cerebrovascular diseases. Dr. Goldstein is Professor of Medicine and Director of the Duke Center for Cerebrovascular Disease at Duke University Medical Center. He is the author or co-author of approximately 100 journal articles and other publications. Clinical management of the patient is the stated focus of the editors who have sought to develop a work accessible to the family or emergency room physician or other non-neurologist, often the first health care provider to see a stroke victim. Beginning with a chapter which reviews some policy issues that have emerged with the new drug treatments, the first section looks at pre-hospital and emergency room management, early recognition and assessment, laboratory investigations, medical complications, and stroke progression.
Treatment is the theme of many of the chapters in the second section.
Here the reader will find discussions related to drug interventions including heparin, antiplatelet agents, heparinoid, thrombolytics, and aspirin. Preventive surgical and drug treatments are also covered. Many of the major clinical trials of both intervening protocols and preventive measures are discussed. All of the chapters have extensive references. There are a few black and white images in appropriate chapters, usually MRI or CT scans.